Both in Pharmaceuticals
MBX Biosciences vs Xencor
Over the past year MBX returned +154.5% and XNCR returned +155.7%; their daily moves had a correlation of 0.31.
MBX +154.5% XNCR +155.7%Growth of $1, one year, split-adjusted
| Metric | MBX | XNCR |
|---|---|---|
| Price | $52.48 | $35.03 |
| Market cap | $2.53B | $2.60B |
| Today | −4.58% | +14.33% |
| 1 month | −7.8% | +43.8% |
| 6 months | +63.4% | +169.3% |
| Year to date | +66.4% | +128.8% |
| 1 year | +154.6% | +151.3% |
| Revenue growth (YoY) | — | +17.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −42.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 24.8× |
| Net cash | — | $351.6M |
| Dividend yield | — | — |
| Volatility (60d) | 48.5% | 67.2% |
| Short % of float | 15.0% | 17.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).